IOF hails WHO report and FRAX Web site as milestones in osteoporosis prevention and treatment | Radiology Articles
LinkedIn Login

Connect healthcare products, companies and hospitals with your LinkedIn network.

Facebook Login

Interact with your Facebook network around healthcare products, companies and hospitals.

Login With Facebook
MedicExchange Login

Enjoy Premium Access as a MedicExchange Member.

       Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Facebook Twitter Linkedin
Facebook: MedicExchange
Twitter: MedicExchange

IOF hails WHO report and FRAX Web site as milestones in osteoporosis prevention and treatment

Radiology News - Radiology Articles
The International Osteoporosis Foundation has welcomed the launch of the WHO technical report 'Assessment of osteoporosis at the primary health care level' and the FRAX website as major steps against the disease. The International Osteoporosis Foundation (IOF) has welcomed the launch of the World Health Organization (WHO) technical report 'Assessment of osteoporosis at the primary health care level' and the FRAX website, as major steps towards helping health professionals worldwide to identify more easily patients at high risk of fracture for treatment.

"The new WHO report and its related FRAX tool which predicts the risk of osteoporosis fracture using clinical risk factors will be of considerable use to health care professionals and policy makers throughout the world, particularly in places where there are few DXA machines. We know that early diagnosis and treatment can save precious healthcare resources so we see the launch of these two assets as a very important milestone in the fight against osteoporosis," said IOF President Professor Pierre D. Delmas.

Assessment of osteoporosis at the primary health care level, authored by Prof. Kanis et al., was released on February 21, 2008. It is a technical report based on epidemiological and health economic analyses of population-based cohorts worldwide. A practical tool, named FRAX, www.shef.ac.uk/FRAX has been developed to predict the ten-year risk of fracture in men and women.

Professor John Kanis noted, "In the report, Assessment of osteoporosis at the primary health care level, cost-effectiveness studies on specific drugs have shown that treating patients on the basis of fracture risk is more cost-effective than treating osteoporotic patients identified only according to bone mineral density (BMD) measurements, for example using the former WHO definition of osteoporosis (1994). The FRAX website provides health professionals with the tool they need to make a more relevant assessment of fracture risk, even when they don't have access to BMD testing."

An individual's risk factors such as age, sex, weight, height and femoral neck BMD if available are entered into the FRAX website, along with information on prior fragility fracture, parental history of hip fracture, current tobacco smoking, long-term use of glucocorticoids, rheumatoid arthritis, other causes of secondary osteoporosis and daily alcohol consumption. The web-based FRAX algorithm then gives a figure indicating a ten-year fracture probability as a percentage, which provides guidance for determining access to treatment in healthcare systems.

Professor Jean-Yves Reginster, IOF General Secretary, added, "There is now widespread acceptance among health care professionals of the need to incorporate fracture risk assessment and cost-effectiveness into decisions about treatment. As osteoporosis-induced fractures cause a great burden to society, cost-effectiveness studies included in this report will help payers and decision-makers to define intervention thresholds for treatment and reimbursement.